Restricted Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any Preferred Shares (other than as contemplated by the Issuance Agreement and this Certificate of Designations and the acquisition of the Theralink Business), or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.
Appears in 3 contracts
Samples: Securities Purchase Agreement (IMAC Holdings, Inc.), Settlement, Assignment and Release Agreement (IMAC Holdings, Inc.), Securities Purchase Agreement (IMAC Holdings, Inc.)
Restricted Issuances. (i) The Company shall not, directly or indirectly, without the prior written consent of the Required HoldersHolders of the Preferred Shares then outstanding, (iA) issue any Preferred Shares (other than as contemplated by the Issuance Agreement and this Certificate of Designations and the acquisition of the Theralink Business), Designations) or (iiB) issue any other securities that would cause a breach or default under this Certificate of Designations or the WarrantsDesignations.
Appears in 2 contracts
Samples: Loan and Security Agreement (Fuelcell Energy Inc), Underwriting Agreement (Fuelcell Energy Inc)
Restricted Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required HoldersHolder, (i) issue any Preferred Shares Other Notes or Warrants (other than as contemplated by the Issuance Agreement and Purchase Agreement, this Certificate of Designations Note and the acquisition of the Theralink Business), Warrants) or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations Note, the Other Note, the Warrants or the WarrantsOther Warrants (as such term is defined in the Purchase Agreement).
Appears in 1 contract
Samples: Panacea Life Sciences Holdings, Inc.
Restricted Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any Preferred Shares (other than as contemplated by the Issuance Securities Purchase Agreement and this Certificate of Designations and the acquisition of the Theralink BusinessDesignations), or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations or the WarrantsWarrants or (iii) enter any agreement with respect to (or otherwise consummate) any Subsequent Placement (other than Excluded Securities).
Appears in 1 contract
Samples: Securities Purchase Agreement (Digital Health Acquisition Corp.)
Restricted Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any Preferred Shares (other than as contemplated by the Issuance Agreement Exchange Agreements and this Certificate of Designations and the acquisition of the Theralink BusinessDesignations), or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations or the WarrantsDesignations.
Appears in 1 contract
Restricted Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any Preferred Shares (other than as contemplated by the Issuance Securities Purchase Agreement and this Certificate of Designations and the acquisition of the Theralink BusinessDesignations), or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.
Appears in 1 contract
Samples: Common Stock Purchase Agreement (Phoenix Biotech Acquisition Corp.)
